Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
Authors
Keywords
-
Journal
Clinical Psychopharmacology and Neuroscience
Volume 18, Issue 3, Pages 423-433
Publisher
Korean College of Neuropsychopharmacology
Online
2020-07-23
DOI
10.9758/cpn.2020.18.3.423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Agomelatine for depression: expanding the horizons?
- (2019) Trevor R. Norman et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants
- (2018) Alessandro Serretti Clinical Psychopharmacology and Neuroscience
- The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients
- (2018) Ebru Fındıklı et al. Clinical Psychopharmacology and Neuroscience
- Korean Medication Algorithm for Depressive Disorders 2017: Third Revision
- (2018) Jeong Seok Seo et al. Clinical Psychopharmacology and Neuroscience
- Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review
- (2018) Jeffrey R. Strawn et al. EXPERT OPINION ON PHARMACOTHERAPY
- Industry sponsorship and research outcome: systematic review with meta-analysis
- (2018) Andreas Lundh et al. INTENSIVE CARE MEDICINE
- Does Melatonin and Melatonin Agonists Improve the Metabolic Side Effects of Atypical Antipsychotics?: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- (2018) Stanley C. Igwe et al. Clinical Psychopharmacology and Neuroscience
- Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study
- (2017) Dan J. Stein et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis
- (2017) Sheng-Min Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A Guide to Conducting a Meta-Analysis
- (2016) Mike W.-L. Cheung et al. NEUROPSYCHOLOGY REVIEW
- The heterogeneity statistic I2 can be biased in small meta-analyses
- (2015) Paul T von Hippel BMC Medical Research Methodology
- Pharmacological treatment for generalized anxiety disorder in adults: an update
- (2015) Jennifer A Reinhold et al. EXPERT OPINION ON PHARMACOTHERAPY
- Risk Factors for Anxiety in Major Depressive Disorder Patients
- (2015) Li-Min Xin et al. Clinical Psychopharmacology and Neuroscience
- Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials
- (2014) Kai-Lin Huang et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Agomelatine in treating generalized anxiety disorder
- (2014) Koen Demyttenaere EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Agomelatine in Generalized Anxiety Disorder
- (2014) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
- (2014) D. Taylor et al. BMJ-British Medical Journal
- The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses
- (2013) W.G. Melsen et al. CLINICAL MICROBIOLOGY AND INFECTION
- New approaches to the pharmacological management of generalized anxiety disorder
- (2013) Massimiliano Buoli et al. EXPERT OPINION ON PHARMACOTHERAPY
- When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed
- (2013) L. Citrome et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Industry Sponsorship and Research Outcome
- (2013) Lisa Bero JAMA Internal Medicine
- Agomelatine Prevents Relapse in Generalized Anxiety Disorder
- (2012) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder
- (2010) Siegfried Kasper et al. JOURNAL OF CLINICAL PSYCHIATRY
- The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats
- (2008) Lisa Conboy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy of Agomelatine in Generalized Anxiety Disorder
- (2008) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Human and economic burden of generalized anxiety disorder
- (2006) Deborah L. Hoffman et al. DEPRESSION AND ANXIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now